Can viruses stop cancer? Researcher looks for answers
Backed by a $2 million grant, University of New Mexico Comprehensive Cancer Center professor Eric Bartee's research raises ...
Research into the low-cost treatments has shown promise, with around 60 clinical trials currently under way
They say these low-cost, high-impact viruses are showing promise in clinical trials – there are around 60 currently under way ...
China’s modified virus therapy shows promise in last-stage cancer trials
A new cancer therapy utilising a genetically modified herpes simplex virus type 1 (HSV-1) offers hope for late-stage patients ...
Tumour meltdown in China therapy tests offers hope to late-stage cancer patients
Experimental therapy uses a modified virus to boost immunity and make anti-tumour treatments more effective, according to ...
Theriva Biologics says IDMC considers VCN-01 to be well tolerated
Theriva announced that a second Independent Data Monitoring Committee review of data from the VIRAGE Phase 2b clinical trial in newly-diagnosed ...
The Jerusalem Post Blogs9d
Oncolytic viruses: The tiny warriors fighting brain cancer
Oncolytic viruses, once considered medical curiosities, are now cutting-edge tools in the fight against some of the most challenging cancers, like glioblastoma. These tiny engineered viruses ...
SynOx Therapeutics Announces Board Chair Transition to Align with Advancing Regulatory and Commercialization Strategy
Sparke, Brings Transatlantic Late-Stage Development, Regulatory and Commercial Expertise Strengthened Leadership and Expanded ...
Fierce Biotech5d
Candel's lung cancer survival data light path toward pivotal trial in subpopulation
Candel Therapeutics has identified a subpopulation of lung cancer patients living longest on its oncolytic virus, leading the biotech to narrow its focus as it heads towards a potentially ...